Pular para o conteúdo
Merck

[SIADH and vaptans].

Annales d'endocrinologie (2012-04-28)
Guy Decaux
RESUMO

The vaptans are non-peptide arginine-vasopressin-receptor antagonists, that are orally and intravenously active. A few vaptans have undergone sufficient clinical development to be on the market. In the EU only tolvaptan is accepted to treat hyponatremia related to SIADH. The place of this new treatment is compared with water restriction, demeclocyclin, furosemide and urea.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Demeclocycline hydrochloride, powder or crystals
Supelco
Demeclocycline hydrochloride hydrate, VETRANAL®, analytical standard